Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolus (EOLS) EPS (Weighted Average and Diluted) (2020 - 2026)

Evolus filings provide 7 years of EPS (Weighted Average and Diluted) readings, the most recent being -$0.16 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 46.67% to -$0.16 in Q1 2026 year-over-year; TTM through Mar 2026 was -$0.67, a 23.86% increase, with the full-year FY2025 number at -$0.8, up 1.23% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.16 in Q1 2026 for Evolus, down from $0.0 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.0 in Q4 2025 to a low of -$0.42 in Q2 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.26 (2023), compared with a mean of -$0.25.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 293.75% in 2022 and later soared 102.02% in 2025.
  • Evolus' EPS (Weighted Average and Diluted) stood at -$0.24 in 2022, then rose by 16.67% to -$0.2 in 2023, then skyrocketed by 50.0% to -$0.1 in 2024, then soared by 102.02% to $0.0 in 2025, then plummeted by 8034.64% to -$0.16 in 2026.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.16 (Q1 2026), $0.0 (Q4 2025), and -$0.24 (Q3 2025) per Business Quant data.